NCT00039520View on ClinicalTrials.gov

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

June 30, 2004

Study Completion Date

July 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

docetaxel

DRUG

sulindac

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT00039520 - Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | Biotech Hunter | Biotech Hunter